Editorials |
From the Department of Exercise Science, University of Iowa, Iowa City.
Correspondence to Gina Schatteman, 406 Field House, Department of Exercise Science, University of Iowa, Iowa City, IA 52242-1111. E-mail gina-schatteman@uiowa.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Single cell bone marrow transplantation leaves no doubt as to the ability of bone marrow cells to differentiate and integrate into the endothelium, though the physiological significance of this remains controversial. Reported rates of bone marrow cell integration into the endothelium after injury vary widely, ranging from almost no cells to large percentages. Bone marrow cell maintenance of the quiescent (ie, nongrowing) vasculature has been less well studied, but at least one mouse study suggests it could be significant.1 Whether or not large numbers of circulating cells integrate into the vessel wall, a consensus seems to be emerging that circulating bone marrowderived cells can promote vascular growth. Exactly how this is accomplished is not clear, though it is presumably due to release of proangiogenic factors.
See page 296
Mobilization of various circulating endothelial cell progenitor (CEP)containing populations correlates with increased vascularization in tissues undergoing neovascularization, and vascular trauma including burns, coronary artery bypass graft, and myocardial infarct all mobilize CEPs.26 In light of these findings, the loss or dysfunction of CEPs could impact on vascular health. Hence, over the past several years a number of studies have begun to examine whether there is a relationship between CEP function and vascular disease. Of course, to do this, one must define a CEP. Therein lies the rub. No consensus has been reached as to what constitutes a CEP, and each laboratory seems to use a different definition. Generally speaking, CEP-containing populations that have been studied fall into two broad categories: cells related
Related Article:
Arterioscler Thromb Vasc Biol 2005 25: 296-301.
This article has been cited by other articles:
![]() |
O. Dotsenko and M. Jahangiri Endogenous stem cells in patients undergoing coronary artery bypass graft surgery Eur. J. Cardiothorac. Surg., September 1, 2009; 36(3): 563 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Fadini, S. V. de Kreutzenberg, A. Coracina, I. Baesso, C. Agostini, A. Tiengo, and A. Avogaro Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk Eur. Heart J., September 2, 2006; 27(18): 2247 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Fadini, A. Coracina, I. Baesso, C. Agostini, A. Tiengo, A. Avogaro, and S. Vigili de Kreutzenberg Peripheral Blood CD34+KDR+ Endothelial Progenitor Cells Are Determinants of Subclinical Atherosclerosis in a Middle-Aged General Population Stroke, September 1, 2006; 37(9): 2277 - 2282. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |